Edgewell Personal Care FY2024 GAAP EPS falls 11%; adjusted EPS rises 18%
Edgewell Personal Care reported fourth-quarter and fiscal 2024 results for the year ended September 30, 2024, and gave a fiscal 2025 outlook. Fourth-quarter net sales fell 3.1% and GAAP diluted EPS dropped to $0.17 from $0.58, while full-year net sales rose 0.1% and adjusted EPS rose 18%. The fiscal 2025 outlook calls for adjusted EPS of $3.15 to $3.35, which would be growth from $3.05, but the weak quarter and higher restructuring charges weigh on near-term results.
Key points
- Q4 fiscal 2024 net sales were $517.6 million, down 3.1%; GAAP diluted EPS was $0.17 versus $0.58 a year earlier
- Fiscal 2024 net sales were $2,253.7 million, up 0.1%; GAAP diluted EPS was $1.97 versus $2.21, and adjusted EPS was $3.05, up 18%
- Fiscal 2025 outlook: adjusted EPS of $3.15 to $3.35 and organic net sales growth of approximately 1% to 3%
- Quarterly cash dividend of $0.15 per share declared October 31, 2024, payable January 8, 2025
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:58 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 07, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.